-
1
-
-
4644279733
-
Increasing prevalence of the metabolic syndrome among U.S. adults
-
Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004;27:2444-9.
-
(2004)
Diabetes Care
, vol.27
, pp. 2444-2449
-
-
Ford, E.S.1
Giles, W.H.2
Mokdad, A.H.3
-
2
-
-
2442647863
-
Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women
-
Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K et al. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004;164:1066-76.
-
(2004)
Arch Intern Med
, vol.164
, pp. 1066-1076
-
-
Hu, G.1
Qiao, Q.2
Tuomilehto, J.3
Balkau, B.4
Borch-Johnsen, K.5
Pyorala, K.6
-
3
-
-
33846048384
-
Relationship between metabolic syndrome and Trp64Arg polymorphism of the β3-adrenergic receptor gene in a general sample: the Shigaraki study
-
Tamaki S, Nakamura Y, Tabara Y, Okamura T, Kita Y, Kadowaki T et al. Relationship between metabolic syndrome and Trp64Arg polymorphism of the β3-adrenergic receptor gene in a general sample: the Shigaraki study. Hypertens Res 2006;29:891-6.
-
(2006)
Hypertens Res
, vol.29
, pp. 891-896
-
-
Tamaki, S.1
Nakamura, Y.2
Tabara, Y.3
Okamura, T.4
Kita, Y.5
Kadowaki, T.6
-
4
-
-
33847630752
-
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis
-
Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007;49:40-7.
-
(2007)
Hypertension
, vol.49
, pp. 40-47
-
-
Mancia, G.1
Bombelli, M.2
Corrao, G.3
Facchetti, R.4
Madotto, F.5
Giannattasio, C.6
-
5
-
-
21544462572
-
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence
-
Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-78.
-
(2005)
Diabetes Care
, vol.28
, pp. 1769-1778
-
-
Ford, E.S.1
-
6
-
-
33748776056
-
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis
-
Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006;119:812-9.
-
(2006)
Am J Med
, vol.119
, pp. 812-819
-
-
Galassi, A.1
Reynolds, K.2
He, J.3
-
7
-
-
20444461614
-
Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study
-
Takeuchi H, Saitoh S, Takagi S, Ohnishi H, Ohhata J, Isobe T et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. Hypertens Res 2005;28:203-8.
-
(2005)
Hypertens Res
, vol.28
, pp. 203-208
-
-
Takeuchi, H.1
Saitoh, S.2
Takagi, S.3
Ohnishi, H.4
Ohhata, J.5
Isobe, T.6
-
8
-
-
34247266656
-
Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome
-
Koji Y, Tomiyama H, Yamada J, Yambe M, Motobe K, Shiina K et al. Relationship between arterial stiffness and the risk of coronary artery disease in subjects with and without metabolic syndrome. Hypertens Res 2007;30:243-7.
-
(2007)
Hypertens Res
, vol.30
, pp. 243-247
-
-
Koji, Y.1
Tomiyama, H.2
Yamada, J.3
Yambe, M.4
Motobe, K.5
Shiina, K.6
-
9
-
-
0038324573
-
Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children
-
Nishina M, Kikuchi T, Yamazaki H, Kameda K, Hiura M, Uchiyama M. Relationship among systolic blood pressure, serum insulin and leptin, and visceral fat accumulation in obese children. Hypertens Res 2003;26:281-8.
-
(2003)
Hypertens Res
, vol.26
, pp. 281-288
-
-
Nishina, M.1
Kikuchi, T.2
Yamazaki, H.3
Kameda, K.4
Hiura, M.5
Uchiyama, M.6
-
10
-
-
17844385849
-
Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children
-
Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res 2005;28:51-7.
-
(2005)
Hypertens Res
, vol.28
, pp. 51-57
-
-
Ogawa, Y.1
Kikuchi, T.2
Nagasaki, K.3
Hiura, M.4
Tanaka, Y.5
Uchiyama, M.6
-
11
-
-
33646572904
-
The metabolic syndrome and adipocytokines
-
Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006;580:2917-21.
-
(2006)
FEBS Lett
, vol.580
, pp. 2917-2921
-
-
Matsuzawa, Y.1
-
12
-
-
33745834319
-
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
-
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006;116:1784-92.
-
(2006)
J Clin Invest
, vol.116
, pp. 1784-1792
-
-
Kadowaki, T.1
Yamauchi, T.2
Kubota, N.3
Hara, K.4
Ueki, K.5
Tobe, K.6
-
13
-
-
34247218635
-
Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study
-
Chiba Y, Saitoh S, Takagi S, Ohnishi H, Katoh N, Ohata J et al. Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu study. Hypertens Res 2007;30:229-36.
-
(2007)
Hypertens Res
, vol.30
, pp. 229-236
-
-
Chiba, Y.1
Saitoh, S.2
Takagi, S.3
Ohnishi, H.4
Katoh, N.5
Ohata, J.6
-
14
-
-
34249003668
-
Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan
-
Eguchi M, Tsuchihashi K, Saitoh S, Odawara Y, Hirano T, Nakata T et al. Visceral obesity in Japanese patients with metabolic syndrome: reappraisal of diagnostic criteria by CT scan. Hypertens Res 2007;30:315-23.
-
(2007)
Hypertens Res
, vol.30
, pp. 315-323
-
-
Eguchi, M.1
Tsuchihashi, K.2
Saitoh, S.3
Odawara, Y.4
Hirano, T.5
Nakata, T.6
-
15
-
-
20444371945
-
The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1)
-
Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP et al. The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc Natl Acad Sci U S A 2005;102:8132-7.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 8132-8137
-
-
Garcia-Calvo, M.1
Lisnock, J.2
Bull, H.G.3
Hawes, B.E.4
Burnett, D.A.5
Braun, M.P.6
-
16
-
-
10744221008
-
Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption
-
Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science 2004;303:1201-4.
-
(2004)
Science
, vol.303
, pp. 1201-1204
-
-
Altmann, S.W.1
Davis Jr., H.R.2
Zhu, L.J.3
Yao, X.4
Hoos, L.M.5
Tetzloff, G.6
-
18
-
-
67650552637
-
Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia
-
Tremblay AJ, Lamarche B, Hogue JC, Couture P. Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia. J Lipid Res 2009;50:1463-71.
-
(2009)
J Lipid Res
, vol.50
, pp. 1463-1471
-
-
Tremblay, A.J.1
Lamarche, B.2
Hogue, J.C.3
Couture, P.4
-
19
-
-
68149126790
-
Ezetimibe improves postprandial hyperlipidemia in patients with type IIb hyperlipidemia
-
Masuda D, Nakagawa-Toyama Y, Nakatani K, Inagaki M, Tsubakio-Yamamoto K, Sandoval JC et al. Ezetimibe improves postprandial hyperlipidemia in patients with type IIb hyperlipidemia. Eur J Clin Invest 2009;39:689-98.
-
(2009)
Eur J Clin Invest
, vol.39
, pp. 689-698
-
-
Masuda, D.1
Nakagawa-Toyama, Y.2
Nakatani, K.3
Inagaki, M.4
Tsubakio-Yamamoto, K.5
Sandoval, J.C.6
-
20
-
-
77952674608
-
Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet
-
Chan DC, Watts GF, Gan SK, Ooi EM, Barrett PH. Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss diet. Diabetes Care 2010;33:1134-9.
-
(2010)
Diabetes Care
, vol.33
, pp. 1134-1139
-
-
Chan, D.C.1
Watts, G.F.2
Gan, S.K.3
Ooi, E.M.4
Barrett, P.H.5
-
21
-
-
76249107102
-
The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia
-
Hiramitsu S, Ishiguro Y, Matsuyama H, Yamada K, Kato K, Noba M et al. The effects of ezetimibe on surrogate markers of cholesterol absorption and synthesis in Japanese patients with dyslipidemia. J Atheroscler Thromb 2010;17:106-14.
-
(2010)
J Atheroscler Thromb
, vol.17
, pp. 106-114
-
-
Hiramitsu, S.1
Ishiguro, Y.2
Matsuyama, H.3
Yamada, K.4
Kato, K.5
Noba, M.6
-
22
-
-
78651473467
-
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
-
Park H, Shima T, Yamaguchi K, Mitsuyoshi H, Minami M, Yasui K et al. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease. J Gastroenterol 2011;46:101-7.
-
(2011)
J Gastroenterol
, vol.46
, pp. 101-107
-
-
Park, H.1
Shima, T.2
Yamaguchi, K.3
Mitsuyoshi, H.4
Minami, M.5
Yasui, K.6
-
23
-
-
36549013633
-
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome
-
Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M et al. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 2007;581:5664-70.
-
(2007)
FEBS Lett
, vol.581
, pp. 5664-5670
-
-
Deushi, M.1
Nomura, M.2
Kawakami, A.3
Haraguchi, M.4
Ito, M.5
Okazaki, M.6
-
24
-
-
84455190243
-
Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress
-
Kurobe H, Aihara K, Higashida M, Hirata Y, Nishiya M, Matsuoka Y et al. Ezetimibe monotherapy ameliorates vascular function in patients with hypercholesterolemia through decreasing oxidative stress. J Atheroscler Thromb 2011;18:1080-9.
-
(2011)
J Atheroscler Thromb
, vol.18
, pp. 1080-1089
-
-
Kurobe, H.1
Aihara, K.2
Higashida, M.3
Hirata, Y.4
Nishiya, M.5
Matsuoka, Y.6
-
25
-
-
29644441199
-
Metabolic syndrome - definition and diagnostic criteria in Japan
-
Matsuzawa Y. Metabolic syndrome - definition and diagnostic criteria in Japan. J Jpn Soc Int Med 2005;94:188-203.
-
(2005)
J Jpn Soc Int Med
, vol.94
, pp. 188-203
-
-
Matsuzawa, Y.1
-
26
-
-
77952304034
-
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
-
Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009;32:3-107.
-
(2009)
Hypertens Res
, vol.32
, pp. 3-107
-
-
Ogihara, T.1
Kikuchi, K.2
Matsuoka, H.3
Fujita, T.4
Higaki, J.5
Horiuchi, M.6
-
27
-
-
65549111017
-
Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan
-
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982-92.
-
(2009)
Am J Kidney Dis
, vol.53
, pp. 982-992
-
-
Matsuo, S.1
Imai, E.2
Horio, M.3
Yasuda, Y.4
Tomita, K.5
Nitta, K.6
-
28
-
-
0032950793
-
Abdominal fat: standardized technique for measurement at CT
-
Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999;211:283-6.
-
(1999)
Radiology
, vol.211
, pp. 283-286
-
-
Yoshizumi, T.1
Nakamura, T.2
Yamane, M.3
Islam, A.H.4
Menju, M.5
Yamasaki, K.6
-
29
-
-
77955519012
-
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
-
Enjoji M, Machida K, Kohjima M, Kato M, Kotoh K, Matsunaga K et al. NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Lipids Health Dis 2010;12:9-29.
-
(2010)
Lipids Health Dis
, vol.12
, pp. 9-29
-
-
Enjoji, M.1
Machida, K.2
Kohjima, M.3
Kato, M.4
Kotoh, K.5
Matsunaga, K.6
-
30
-
-
74049143227
-
A catalogue of reporting guidelines for health research
-
Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
-
(2010)
Eur J Clin Invest
, vol.40
, pp. 35-53
-
-
Simera, I.1
Moher, D.2
Hoey, J.3
Schulz, K.F.4
Altman, D.G.5
-
31
-
-
77954366025
-
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study
-
Yoneda M, Fujita K, Nozaki Y, Endo H, Takahashi H, Hosono K et al. Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: an open-label, pilot study. Hepatol Res 2010;40:613-21.
-
(2010)
Hepatol Res
, vol.40
, pp. 613-621
-
-
Yoneda, M.1
Fujita, K.2
Nozaki, Y.3
Endo, H.4
Takahashi, H.5
Hosono, K.6
-
32
-
-
57349106472
-
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice
-
Labonté ED, Camarota LM, Rojas JC, Jandacek RJ, Gilham DE, Davies JP et al. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice. Am J Physiol Gastrointest Liver Physiol 2008;295:G776-83.
-
(2008)
Am J Physiol Gastrointest Liver Physiol
, vol.295
-
-
Labonté, E.D.1
Camarota, L.M.2
Rojas, J.C.3
Jandacek, R.J.4
Gilham, D.E.5
Davies, J.P.6
-
33
-
-
34547726814
-
Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects
-
Sato F, Tamura Y, Watada H, Kumashiro N, Igarashi Y, Uchino H et al. Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects. J Clin Endocrinol Metab 2007;92:3326-9.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 3326-3329
-
-
Sato, F.1
Tamura, Y.2
Watada, H.3
Kumashiro, N.4
Igarashi, Y.5
Uchino, H.6
|